•
Jun 30, 2024

agilon health Q2 2024 Earnings Report

agilon health's Q2 2024 results were reported, showing revenue increase and maintained medical margin and Adjusted EBITDA guidance.

Key Takeaways

agilon health reported a 39% increase in revenue to $1.48 billion for Q2 2024. The company is maintaining its medical margin and Adjusted EBITDA guidance for the full year.

Total members on the agilon platform increased to 645,000 as of June 30, 2024, including 513,000 Medicare Advantage members and 132,000 ACO model beneficiaries.

Medicare Advantage membership increased 38%, with 6% growth in same partner geographies.

Total revenue of $1.48 billion in the second quarter 2024 increased 39% compared to $1.07 billion in the second quarter 2023.

Net loss was $31 million in the second quarter 2024 compared to $17 million in the second quarter 2023.

Total Revenue
$1.48B
Previous year: $1.15B
+29.0%
EPS
-$0.07
Previous year: -$0.04
+75.0%
Medicare Advantage Members
513K
Previous year: 408.9K
+25.5%
Average MA Membership
507K
Previous year: 409.7K
+23.7%
Gross Profit
$32M
Previous year: $57M
-43.9%
Cash and Equivalents
$109M
Previous year: $191M
-42.7%
Free Cash Flow
-$22M
Total Assets
$2.16B
Previous year: $2.35B
-8.1%

agilon health

agilon health

agilon health Revenue by Segment

Forward Guidance

agilon health maintains its 2024 Medical Margin and Adjusted EBITDA Guidance.

Revenue & Expenses

Visualization of income flow from segment revenue to net income